Patient outcomes after therapy with 177 Lu-PSMA-617 (LuPSMA) for metastatic castrate-resistant prostate cancer (mCRPC): A tertiary center experience.
| Autor: | Losee, Meryam, Vaz, Nuno, Ritzer, Jolivette, Wolanski, Andrew, Bhimaniya, Sudhir, Choudhury, Atish Dipankar, Hyun, Hyewon, Kelly, Emma, Kilbridge, Kerry L., Morgans, Alicia K., Pomerantz, Mark, Robertson, Matthew, Sakellis, Christopher, Shah, Hina, Sunkara, Rajitha, Taplin, Mary-Ellen, Wei, Xiao X., Whelpley, Bridget, Ravi, Praful, Jacene, Heather |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p87-87, 235p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|